A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rhinitis, Allergic Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Nose Diseases Otorhinolaryngologic Diseases Respiratory Hypersensitivity Respiratory Tract Diseases Rhinitis

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Many locations

Multiple Locations, Mexico

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
Participants allowing to use the data for research and marketing purposes as well as talking to authorities
Participants allowing us to use the pseudo-randomized individual data for further data analysis
Able to read and understand the language of the online questionnaire

Exclusion criteria

None

Treatment and study plan

Online survey

Other

Participants will be invited to complete an online questionnaire about their experience of product use.

Primary outcomes

Experience with betamethasone plus loratadine via an online questionnaire

Time frame: 2 months

Participants' experiences with betamethasone plus loratadine used under real life conditions.

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Nov 27, 2020
Registry last updated: Jun 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed